Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00340756 · ClinicalTrials.gov registry record
Evaluating Serum Sex Steroid Hormones
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 60
- Enrollment target
NCT00340756: Completed study, sponsored by National Cancer Institute (NCI).
NCT00340756 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00340756 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the reproducibility of measurements of sex hormone levels in serum samples. Researchers will collect blood from 60 healthy adults, including 20 men, 20 premenopausal women, and 20 postmenopausal women. Blood samples will be collected after study participants have fasted overnight.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2003-08-06 |
| Est. Completion | 2011-02-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00340756
The ClinicalTrials.gov registry entry for NCT00340756 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00340756 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00340756 about?
NCT00340756 is a clinical study titled "Evaluating Serum Sex Steroid Hormones". The purpose of this study is to evaluate the reproducibility of measurements of sex hormone levels in serum samples. Researchers will collect blood from 60 healthy adults, including 20 men, 20 premenopausal women, and 20 postmenopausal women. Blood samples will be collected after study participants ...
What is the current status of trial NCT00340756?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2003-08-06. Estimated completion is 2011-02-25.
Who is sponsoring clinical trial NCT00340756?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.